Join the Oncology Voice Network. Join for Free
The ART of Excellence... How to be a Rock Star MSL
medical affairs industry writing process adaptability resilience MSLs

The ART of Excellence... How to be a Rock Star MSL


Share This Article


Summary

In this episode, Cathy Andorfer joins Tom Caravela to discuss her new book and the journey of writing it. Cathy shares insights into her writing process, addressing challenges and the evolving landscape of the medical affairs industry. The conversation highlights the significance of adaptability and resilience for MSLs, along with maintaining a positive mindset amidst industry changes. Cathy reflects on the importance of these traits in her career and provides a glimpse into future industry trends. The episode wraps up with expressions of gratitude and a reminder about the upcoming Mass West event, followed by credits and sponsor information.

In this week’s episode, Cathy Andorfer, National MSL Director shares The ART of Excellence…How to become a Rock Star MSL

Click for Source
medical affairs industry, writing process, adaptability, resilience, MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Healthy on the Road-How to Avoid MSL Belly
Partner Avatar MSL Talk: Tom Caravela, Alex Palumbo

Healthy on the Road-How to Avoid MSL Belly

Podcast
The Strategic vs the Scientific MSL
Partner Avatar MSL Talk: Tom Caravela, Joy Morrell

The Strategic vs the Scientific MSL

Article
Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology
OVN Avatar Yan Ji, Jin Y. Jin, David M. Hyman, Geoffrey Kim and Ajit Suri

Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology

Article
The Oncology Data Network (ODN): Methodology, Challenges, and Achievements
OVN Avatar Ashley Woolmore , Dirk Arnold , Jean‐Yves Blay , Christian Buske , Alfredo Carrato , Winald Gerritsen , Marc Peeters , Jesus Garcia‐Foncillas , David Kerr

The Oncology Data Network (ODN): Methodology, Challenges, and Achievements

Article
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
OVN Avatar Alyson Haslam, PhD; Vinay Prasad, MD, MPH

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs

Article
Loose Regulatory Standards Portend a New Era of Imprecision Oncology
OVN Avatar Ali Raza Khaki

Loose Regulatory Standards Portend a New Era of Imprecision Oncology

Explore OVN